Thermo Fisher Scientific Launches New LIMS for Clinical Laboratories at AACC 2011
July 27, 2011
ATLANTA – Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of a new informatics solution to support clinical laboratories serving the emerging fields of translational and personalized medicine. Thermo Scientific Clinical LIMS (laboratory information management system) is a fully functional data and sample management system that is designed to [...]
Takeda Expands Research with Genedata Expressionist for Mass Spectrometry
July 27, 2011
Tokyo, Japan - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced Takeda Pharmaceutical Company expanded its Genedata Expressionist® licensing. Takeda uses Genedata Expressionist for managing and analyzing massive amounts of mass spectrometry (MS) data for a wide variety of metabolomics and proteomics applications. With the release [...]
Record Year for CEM’s Peptide Synthesis Business
July 27, 2011
MATTHEWS, N.C. - CEM Corporation, a leading global provider of microwave laboratory instrumentation, continues to see strong success with its microwave peptide synthesis products. In FY2011 year-to-date, the company has seen significant growth versus the prior year in its automated peptide synthesizer instrument sales and is on pace to easily sell a record number of [...]
Rheonix Announces New SeptiCARD Data Demonstrating Rapid Septicemia Diagnosis
July 27, 2011
ITHACA, N.Y. - Rheonix, Inc. today announced positive results in a new application of its powerful, automated, molecular diagnostic platform, termed SeptiCARD, for the detection of septicemia, the presence of bacteria in the blood often associated with severe infection. Results were presented in a poster session at the American Association for Clinical Chemistry (AACC) Annual [...]
July 26, 2011
Franklin Lakes, NJ - The Board of Directors of BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that, in accordance with its long-term succession planning, it has elected Vincent A. Forlenza as Chief Executive Officer and President, effective October 1, 2011. Mr. Forlenza will also become a member of [...]
Thermo Fisher Scientific Expands Access to Drug Monitoring Reagents
July 26, 2011
ATLANTA -- Thermo Fisher Scientific Inc., the world leader in serving science, today announced validated applications for Thermo Scientific immunoassays on Ortho Clinical Diagnostics' VITROS® Systems. There are seven new manufacturer validated applications (MVA) which include: CEDIA® Cyclosporine Plus (including separate applications for both low and high range), CEDIA® Tacrolimus and CEDIA® Mycophenolic Acid assays [...]
Thermo Fisher Scientific Launches New Oral Fluid Immunoassays
July 26, 2011
ATLANTA -- Thermo Fisher Scientific Inc., the world leader in serving science, today announced U.S. Food and Drug Administration clearance and launch of six new Thermo Scientific Oral Fluid Drugs of Abuse immunoassays that test for amphetamines, cannabinoids (THC), cocaine, methamphetamines, opiates, and PCP. The Thermo Scientific reagents complement the patented Oral-Eze oral fluid specimen [...]
Roche Submits Acute Hepatitis B Test to FDA for Premarket Approval
July 26, 2011
INDIANAPOLIS - Roche announced today that it has submitted a Premarket Approval Application (PMA) to the U.S. Food and Drug Administration (FDA) for the Elecsys Anti-HBc IgM assay for use on the cobas e 411, cobas e 601 and MODULAR ANALYTICS E170 analyzers. The hepatitis B test represents the final component of the acute panel [...]
July 26, 2011
Kuala Lumpur, Malaysia - Sengenics today announced the introduction of a new microarray based genetic diagnostics test into Asia. The microarray used for the test was designed by Oxford Gene Technology (OGT), UK in conjunction with Emory Genetics, USA. Microarrays are now recommended as the most effective method for diagnosing children's disorders. This was published [...]
Caliper Announces CE IVD Mark for LabChip® Dx for Clinical Patient Sample Testing
July 26, 2011
HOPKINTON, Mass. - Caliper Life Sciences, Inc. (NASDAQ: CALP) announced today that its new, innovative LabChip® Dx instrument has achieved CE IVD registration in Europe. The LabChip Dx, a novel instrument based on Caliper's robust LabChip microfluidics technology, will now be marketed and sold in Europe with the CE IVD Mark under the European Directive [...]
